(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval allows doctors to prescribe Ozempic specifically to lower the risk of kidney ...

Amid a deluge of executive actions, the Trump administration has directed federal health agencies to pause external ...

(Reuters) - The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner ...

French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts' estimates on Thursday, and said it ...

Eisai (ESAIY) and Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has approved the Supplemental Biologics License Application, sBLA, for once every four weeks lecanemab ...

Johnson & Johnson announced the U.S. FDA approval of a supplemental New Drug Application for Spravato CIII nasal spray, making this innovative treatment the first and only monotherapy for adults ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

Hi, it’s Amber in Hong Kong. For many of us, drug labels can be impossible to decipher. A small change may help. But before I ...

Rats infested the Houston Police Department's evidence room and broke into a package of mushrooms, possibly disrupting open ...

The Food and Drug Administration OK’d 10 Zyn flavors, including coffee, mint and menthol. It’s the first time regulators have authorized sales of nicotine pouches, which are the fastest ...

A growing pool of studies finds concerning levels of plastic and forever chemicals in our common food items and their ...